nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—hindbrain—Parkinson's disease	0.0459	0.137	CbGeAlD
Auranofin—PRDX5—embryo—Parkinson's disease	0.0287	0.0854	CbGeAlD
Auranofin—PRDX5—brainstem—Parkinson's disease	0.0263	0.0782	CbGeAlD
Auranofin—PRDX5—forebrain—Parkinson's disease	0.0254	0.0755	CbGeAlD
Auranofin—PRDX5—cardiovascular system—Parkinson's disease	0.0215	0.0638	CbGeAlD
Auranofin—PRDX5—medulla oblongata—Parkinson's disease	0.0184	0.0546	CbGeAlD
Auranofin—IKBKB—embryo—Parkinson's disease	0.017	0.0506	CbGeAlD
Auranofin—PRDX5—midbrain—Parkinson's disease	0.0168	0.0499	CbGeAlD
Auranofin—PRDX5—spinal cord—Parkinson's disease	0.0164	0.0486	CbGeAlD
Auranofin—PRDX5—head—Parkinson's disease	0.0145	0.0432	CbGeAlD
Auranofin—PRDX5—nervous system—Parkinson's disease	0.0138	0.041	CbGeAlD
Auranofin—PRDX5—central nervous system—Parkinson's disease	0.0133	0.0395	CbGeAlD
Auranofin—PRDX5—cerebellum—Parkinson's disease	0.013	0.0386	CbGeAlD
Auranofin—IKBKB—cardiovascular system—Parkinson's disease	0.0127	0.0378	CbGeAlD
Auranofin—PRDX5—brain—Parkinson's disease	0.0105	0.0313	CbGeAlD
Auranofin—IKBKB—head—Parkinson's disease	0.00862	0.0256	CbGeAlD
Auranofin—IKBKB—nervous system—Parkinson's disease	0.00817	0.0243	CbGeAlD
Auranofin—IKBKB—central nervous system—Parkinson's disease	0.00786	0.0234	CbGeAlD
Auranofin—IKBKB—cerebellum—Parkinson's disease	0.00769	0.0228	CbGeAlD
Auranofin—IKBKB—brain—Parkinson's disease	0.00624	0.0186	CbGeAlD
Auranofin—ALB—brain—Parkinson's disease	0.00364	0.0108	CbGeAlD
Auranofin—IKBKB—TWEAK Signaling Pathway—CASP3—Parkinson's disease	0.00148	0.00223	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGF20—Parkinson's disease	0.00147	0.00221	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—DGKQ—Parkinson's disease	0.00146	0.0022	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAG—Parkinson's disease	0.00145	0.00218	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SOD1—Parkinson's disease	0.00142	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—FASLG—Parkinson's disease	0.00141	0.00213	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—INS—Parkinson's disease	0.00138	0.00208	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—GRIN2B—Parkinson's disease	0.00137	0.00207	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—MAPK8—Parkinson's disease	0.00136	0.00205	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—FGB—Parkinson's disease	0.00134	0.00202	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HGF—Parkinson's disease	0.00133	0.002	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—HSPA8—Parkinson's disease	0.00132	0.002	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00131	0.00198	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SOD2—Parkinson's disease	0.00128	0.00193	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—FGB—Parkinson's disease	0.00127	0.00192	CbGpPWpGaD
Auranofin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—Parkinson's disease	0.00125	0.00189	CbGpPWpGaD
Auranofin—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—MAPK8—Parkinson's disease	0.00124	0.00187	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DRA—Parkinson's disease	0.00123	0.00185	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—HSPA1A—Parkinson's disease	0.00121	0.00182	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—MAPK8—Parkinson's disease	0.0012	0.00181	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—IL1B—Parkinson's disease	0.00119	0.0018	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD1—Parkinson's disease	0.00116	0.00175	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—MTHFR—Parkinson's disease	0.00113	0.0017	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—BDNF—Parkinson's disease	0.0011	0.00166	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—MAPK8—Parkinson's disease	0.00109	0.00165	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—MAPK8—Parkinson's disease	0.00109	0.00165	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—MAPK8—Parkinson's disease	0.00109	0.00165	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGF20—Parkinson's disease	0.00108	0.00163	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—Parkinson's disease	0.00107	0.00162	CbGpPWpGaD
Auranofin—ALB—Lipid and lipoprotein metabolism—APOE—Parkinson's disease	0.00107	0.00161	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—APOE—Parkinson's disease	0.00105	0.00158	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ADORA2A—Parkinson's disease	0.00105	0.00158	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD2—Parkinson's disease	0.00104	0.00157	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP3—Parkinson's disease	0.00103	0.00155	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00101	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—MAPK8—Parkinson's disease	0.00101	0.00152	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—Parkinson's disease	0.000999	0.00151	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—GPX1—Parkinson's disease	0.000995	0.0015	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—SOD1—Parkinson's disease	0.000993	0.0015	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP3—Parkinson's disease	0.000993	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IGF1R—Parkinson's disease	0.000991	0.00149	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—NGF—Parkinson's disease	0.000979	0.00148	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BDNF—Parkinson's disease	0.000975	0.00147	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.000946	0.00143	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—MAPK8—Parkinson's disease	0.000946	0.00143	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—IGF2—Parkinson's disease	0.000944	0.00142	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—MAPK8—Parkinson's disease	0.000934	0.00141	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MAPK8—Parkinson's disease	0.000934	0.00141	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—IL1B—Parkinson's disease	0.000931	0.0014	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00092	0.00139	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MTHFR—Parkinson's disease	0.000918	0.00138	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—MAPK8—Parkinson's disease	0.000913	0.00138	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.000899	0.00135	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	0.000898	0.00135	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—HGF—Parkinson's disease	0.000891	0.00134	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—Parkinson's disease	0.000867	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—Parkinson's disease	0.000866	0.00131	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—FASLG—Parkinson's disease	0.000866	0.0013	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NGF—Parkinson's disease	0.000866	0.0013	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—CASP3—Parkinson's disease	0.000865	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—MAPK8—Parkinson's disease	0.000854	0.00129	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK8—Parkinson's disease	0.000854	0.00129	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.000849	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP3—Parkinson's disease	0.000848	0.00128	CbGpPWpGaD
Auranofin—ALB—Hemostasis—DOCK3—Parkinson's disease	0.000845	0.00127	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MERTK—Parkinson's disease	0.000845	0.00127	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.000829	0.00125	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL1B—Parkinson's disease	0.000805	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP3—Parkinson's disease	0.000796	0.0012	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—MAPK8—Parkinson's disease	0.000795	0.0012	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ADRBK1—Parkinson's disease	0.000794	0.0012	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.000791	0.00119	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP3—Parkinson's disease	0.000789	0.00119	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—Parkinson's disease	0.00078	0.00118	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—MAPK8—Parkinson's disease	0.000772	0.00116	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—Parkinson's disease	0.000765	0.00115	CbGpPWpGaD
Auranofin—ALB—Hemostasis—DGKQ—Parkinson's disease	0.000753	0.00113	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—MAPK8—Parkinson's disease	0.000751	0.00113	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.000738	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—MAPK8—Parkinson's disease	0.000731	0.0011	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—INS—Parkinson's disease	0.00073	0.0011	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00073	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—Parkinson's disease	0.000728	0.0011	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—DCTN1—Parkinson's disease	0.000726	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—Parkinson's disease	0.000725	0.00109	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—MAPK8—Parkinson's disease	0.000725	0.00109	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—MAPK8—Parkinson's disease	0.000713	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL1B—Parkinson's disease	0.000696	0.00105	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.000695	0.00105	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—MAPK8—Parkinson's disease	0.000684	0.00103	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000681	0.00103	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PLA2G6—Parkinson's disease	0.00068	0.00103	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00067	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.000668	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DRA—Parkinson's disease	0.00066	0.000995	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000652	0.000982	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000652	0.000982	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000626	0.000944	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HGF—Parkinson's disease	0.000619	0.000933	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Parkinson's disease	0.000617	0.00093	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—Parkinson's disease	0.000617	0.00093	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGF20—Parkinson's disease	0.000616	0.000929	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—MAPK8—Parkinson's disease	0.000615	0.000927	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PARK2—Parkinson's disease	0.000596	0.000899	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.000593	0.000894	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGF20—Parkinson's disease	0.000592	0.000892	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VPS35—Parkinson's disease	0.000583	0.000878	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000583	0.000878	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.00058	0.000875	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—Parkinson's disease	0.000579	0.000872	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—Parkinson's disease	0.000574	0.000865	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	0.000568	0.000857	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NGF—Parkinson's disease	0.000566	0.000853	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CASP3—Parkinson's disease	0.000551	0.000831	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Parkinson's disease	0.000545	0.000822	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000545	0.000822	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Parkinson's disease	0.000528	0.000796	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	0.000521	0.000786	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.000515	0.000777	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000507	0.000764	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000493	0.000743	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.000489	0.000737	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—Parkinson's disease	0.000488	0.000736	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—Parkinson's disease	0.000487	0.000734	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000486	0.000733	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAG—Parkinson's disease	0.000485	0.000731	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GPR37—Parkinson's disease	0.000483	0.000728	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DGKQ—Parkinson's disease	0.000483	0.000728	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.00048	0.000723	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—Parkinson's disease	0.000471	0.00071	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK8—Parkinson's disease	0.000466	0.000702	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.000463	0.000698	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—Parkinson's disease	0.000463	0.000698	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—Parkinson's disease	0.000455	0.000686	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ADRBK1—Parkinson's disease	0.000453	0.000682	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK8—Parkinson's disease	0.000448	0.000675	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000446	0.000673	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000442	0.000666	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000441	0.000664	CbGpPWpGaD
Auranofin—IKBKB—Immune System—DCTN1—Parkinson's disease	0.00044	0.000663	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—Parkinson's disease	0.000437	0.000658	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000433	0.000653	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	0.00043	0.000647	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	0.000426	0.000643	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000419	0.000631	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	0.000412	0.000622	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—Parkinson's disease	0.000407	0.000614	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRA—Parkinson's disease	0.0004	0.000604	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PLA2G6—Parkinson's disease	0.000396	0.000597	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—Parkinson's disease	0.000396	0.000596	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000395	0.000596	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—Parkinson's disease	0.000393	0.000592	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000392	0.000591	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RIT2—Parkinson's disease	0.000386	0.000582	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000369	0.000557	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ABL1—Parkinson's disease	0.000369	0.000556	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRK5—Parkinson's disease	0.000366	0.000552	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000364	0.000548	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PARK2—Parkinson's disease	0.000362	0.000545	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF20—Parkinson's disease	0.000359	0.000541	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—Parkinson's disease	0.000354	0.000534	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000346	0.000521	CbGpPWpGaD
Auranofin—ALB—Metabolism—ND3—Parkinson's disease	0.000342	0.000516	CbGpPWpGaD
Auranofin—ALB—Metabolism—MCCC1—Parkinson's disease	0.000342	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.000333	0.000502	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000329	0.000496	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM4—Parkinson's disease	0.000328	0.000495	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000325	0.000489	CbGpPWpGaD
Auranofin—ALB—Metabolism—TALDO1—Parkinson's disease	0.000322	0.000485	CbGpPWpGaD
Auranofin—ALB—Metabolism—OMD—Parkinson's disease	0.000322	0.000485	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000319	0.000481	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—Parkinson's disease	0.000318	0.00048	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000318	0.00048	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000314	0.000474	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PENK—Parkinson's disease	0.000311	0.000469	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAG—Parkinson's disease	0.000311	0.000469	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FGB—Parkinson's disease	0.000306	0.000461	CbGpPWpGaD
Auranofin—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000305	0.00046	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—Parkinson's disease	0.000293	0.000441	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCH1—Parkinson's disease	0.000291	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDYN—Parkinson's disease	0.000285	0.000429	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000274	0.000413	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GFAP—Parkinson's disease	0.000268	0.000403	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRM5—Parkinson's disease	0.000265	0.000399	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ADRBK1—Parkinson's disease	0.000264	0.000397	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000263	0.000396	CbGpPWpGaD
Auranofin—ALB—Metabolism—FBP1—Parkinson's disease	0.00026	0.000391	CbGpPWpGaD
Auranofin—ALB—Metabolism—GBA—Parkinson's disease	0.00026	0.000391	CbGpPWpGaD
Auranofin—ALB—Metabolism—DBH—Parkinson's disease	0.00026	0.000391	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000254	0.000382	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF20—Parkinson's disease	0.000232	0.00035	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SOD1—Parkinson's disease	0.000227	0.000342	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000227	0.000342	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADORA2A—Parkinson's disease	0.000225	0.000339	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000218	0.000328	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ABL1—Parkinson's disease	0.000217	0.000327	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—Parkinson's disease	0.000216	0.000325	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ABL1—Parkinson's disease	0.000215	0.000324	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INSR—Parkinson's disease	0.000208	0.000313	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HGF—Parkinson's disease	0.000204	0.000307	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HGF—Parkinson's disease	0.000202	0.000305	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGB—Parkinson's disease	0.000196	0.000296	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR1A—Parkinson's disease	0.000195	0.000294	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAC1—Parkinson's disease	0.000192	0.00029	CbGpPWpGaD
Auranofin—ALB—Metabolism—DDC—Parkinson's disease	0.00019	0.000287	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.00019	0.000286	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000189	0.000285	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD1—Parkinson's disease	0.000189	0.000284	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—Parkinson's disease	0.000187	0.000282	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD3—Parkinson's disease	0.000183	0.000275	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000182	0.000274	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA4—Parkinson's disease	0.00018	0.000271	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000178	0.000268	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRBK1—Parkinson's disease	0.00017	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—Parkinson's disease	0.000167	0.000252	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD2—Parkinson's disease	0.000165	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR7—Parkinson's disease	0.000165	0.000249	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G6—Parkinson's disease	0.000162	0.000244	CbGpPWpGaD
Auranofin—ALB—Metabolism—MAOB—Parkinson's disease	0.00016	0.000242	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000153	0.00023	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—Parkinson's disease	0.000138	0.000209	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—Parkinson's disease	0.000134	0.000202	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDN1—Parkinson's disease	0.000132	0.000199	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGF—Parkinson's disease	0.000121	0.000183	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000119	0.00018	CbGpPWpGaD
Auranofin—ALB—Metabolism—CTGF—Parkinson's disease	0.000117	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2A—Parkinson's disease	0.000116	0.000174	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000109	0.000164	CbGpPWpGaD
Auranofin—ALB—Metabolism—NQO1—Parkinson's disease	0.000108	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—Parkinson's disease	0.000108	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—Parkinson's disease	0.000107	0.000161	CbGpPWpGaD
Auranofin—ALB—Metabolism—TH—Parkinson's disease	0.000106	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—Parkinson's disease	0.000106	0.00016	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYCS—Parkinson's disease	0.000102	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—Parkinson's disease	9.72e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—Parkinson's disease	9.19e-05	0.000138	CbGpPWpGaD
Auranofin—ALB—Metabolism—COMT—Parkinson's disease	9.03e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—Parkinson's disease	8.99e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—MAOA—Parkinson's disease	8.97e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—Parkinson's disease	8.86e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—Parkinson's disease	8.51e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—Parkinson's disease	8.26e-05	0.000124	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—Parkinson's disease	7.91e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—Parkinson's disease	7.3e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—Parkinson's disease	6.84e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—Parkinson's disease	6.8e-05	0.000102	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—Parkinson's disease	6.29e-05	9.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—Parkinson's disease	6.21e-05	9.36e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—Parkinson's disease	5.81e-05	8.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—Parkinson's disease	4.01e-05	6.05e-05	CbGpPWpGaD
